Search Results

LCL-161 10mg 10mg  | Purity Not Available

Adooq Bioscience

LCL161 is an orally bioavailable second mitochondrial-derived activator of caspases (SMAC) mimetic and inhibitor of IAP (Inhibitor of Apoptosis Protein) family of proteins, with potential antineoplastic activity.

More Information Supplier Page

R788 5mg 5mg  | Purity Not Available

Adooq Bioscience

R788 (Fostamatinib) is an important spleen tyrosine kinase (Syk) inhibitor, showing efficacy against kinase-mediated IgG Fc gamma receptor signaling.

More Information Supplier Page

R788 25mg 25mg  | Purity Not Available

Adooq Bioscience

R788 (Fostamatinib) is an important spleen tyrosine kinase (Syk) inhibitor, showing efficacy against kinase-mediated IgG Fc gamma receptor signaling.

More Information Supplier Page

R788 2mg 2mg  | Purity Not Available

Adooq Bioscience

R788 (Fostamatinib) is an important spleen tyrosine kinase (Syk) inhibitor, showing efficacy against kinase-mediated IgG Fc gamma receptor signaling.

More Information Supplier Page

R788 10mg 10mg  | Purity Not Available

Adooq Bioscience

R788 (Fostamatinib) is an important spleen tyrosine kinase (Syk) inhibitor, showing efficacy against kinase-mediated IgG Fc gamma receptor signaling.

More Information Supplier Page

LCL-161 25mg 25mg  | Purity Not Available

Adooq Bioscience

LCL161 is an orally bioavailable second mitochondrial-derived activator of caspases (SMAC) mimetic and inhibitor of IAP (Inhibitor of Apoptosis Protein) family of proteins, with potential antineoplastic activity.

More Information Supplier Page

LCL-161 5mg 5mg  | Purity Not Available

Adooq Bioscience

LCL161 is an orally bioavailable second mitochondrial-derived activator of caspases (SMAC) mimetic and inhibitor of IAP (Inhibitor of Apoptosis Protein) family of proteins, with potential antineoplastic activity.

More Information Supplier Page